Erratum to: A multi-stage genome-wide association study of uterine fibroids in African Americans.
Erratum to: A multi-stage genome-wide association study of uterine fibroids in African Americans.
复制标题
勘误:非裔美国人子宫肌瘤的多阶段全基因组关联研究。
DOI:
10.1007/s00439-017-1846-z
复制
发表时间:
2017
期刊:
影响因子:
5.3
通讯作者:
P
中科院分区:
文献类型:
--
作者:
Hellwege,JacklynN;Jeff,JaninaM;Wise,LaurenA;Gallagher,CScott;Wellons,Melissa;Hartmann,KatherineE;Jones,SarahF;Torstenson,EricS;Dickinson,Scott;Ruiz-Narváez,EdwardA;Rohland,Nadin;Allen,Alexander;Reich,David;Tandon,Arti;P
Uterine fibroids are benign tumors of the uterus affecting up to 77% of women by menopause. They are the leading indication for hysterectomy, and account for $34 billion annually in the United States. Race/ethnicity and age are the strongest known risk factors. African American (AA) women have higher prevalence, earlier onset, and larger and more numerous fibroids than European American women. We conducted a multi-stage genome-wide association study (GWAS) of fibroid risk among AA women followed by in silico genetically predicted gene expression profiling of top hits. In Stage 1, cases and controls were confirmed by pelvic imaging, genotyped and imputed to 1000 Genomes. Stage 2 used self-reported fibroid and GWAS data from 23andMe, Inc. and the Black Women’s Health Study. Associations with fibroid risk were modeled using logistic regression adjusted for principal components, followed by meta-analysis of results. We observed a significant association among 3399 AA cases and 4764 AA controls at rs739187 (risk-allele frequency = 0.27) inCYTH4(OR (95% confidence interval) = 1.23 (1.16–1.30),pvalue = 7.82 × 10−9). Evaluation of the genetic association results with MetaXcan identified lower predicted gene expression ofCYTH4in thyroid tissue as significantly associated with fibroid risk (pvalue = 5.86 × 10−8). In this first multi-stage GWAS for fibroids among AA women, we identified a novel risk locus for fibroids withinCYTH4that impacts gene expression in thyroid and has potential biological relevance for fibroids.